Demant A/SDEMANT.CO

Nasdaq CopenhagenHealthcareMedical Devices
Price (close)
DKK 307.20
Market cap
DKK 64.8B
P/E
41.9x
Revenue (FY)
DKK 23.0B
Net income
DKK 1.5B
Dividend yield
—
1-year total return
29.1%
Net margin
6.7%
Revenue growth
2.5%
Debt / equity
1.79x

What Demant A/S does.

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
RevenueDKK 14.5BDKK 17.9BDKK 19.7BDKK 21.6BDKK 22.4BDKK 23.0B
Net incomeDKK 1.1BDKK 2.5BDKK 2.1BDKK 1.8BDKK 2.4BDKK 1.5B
Free cash flowDKK 2.1BDKK 3.0BDKK 2.0BDKK 3.8BDKK 3.5BDKK 3.2B

More on DEMANT.CO.

Figures from Demant A/S's annual reports (ESEF, via filings.xbrl.org) and Yahoo Finance, standardised automatically; prices are end-of-day closes. Not financial advice.